Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Dakshesh Patel, Jayna Stohlman, Qianyu Dang, et al.
Toxicological Sciences (2019) Vol. 170, Iss. 1, pp. 167-179
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cardiac optogenetics: a decade of enlightenment
Emilia Entcheva, Matthew W. Kay
Nature Reviews Cardiology (2020) Vol. 18, Iss. 5, pp. 349-367
Open Access | Times Cited: 131
Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs
Ksenia Blinova, Derek Schocken, Dakshesh Patel, et al.
Clinical and Translational Science (2019) Vol. 12, Iss. 6, pp. 687-697
Open Access | Times Cited: 47
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases
Marc Pourrier, David Fedida
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 657-657
Open Access | Times Cited: 46
Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations
Gary Gintant, Emily Pfeiffer Kaushik, Tromondae K. Feaster, et al.
Regulatory Toxicology and Pharmacology (2020) Vol. 117, pp. 104756-104756
Open Access | Times Cited: 42
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes
Kavita Raniga, Aishah Nasir, Nguyen T.N. Vo, et al.
Cell stem cell (2024) Vol. 31, Iss. 3, pp. 292-311
Open Access | Times Cited: 5
Olmesartan Restores LMNA Function in Haploinsufficient Cardiomyocytes
Eric J. Kort, Nazish Sayed, Chun Liu, et al.
Circulation (2025)
Closed Access
Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
Akshay Narkar, James M. Willard, Ksenia Blinova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3199-3199
Open Access | Times Cited: 21
In situ monolayer patch clamp of acutely stimulated human iPSC-derived cardiomyocytes promotes consistent electrophysiological responses to SK channel inhibition
Andrew S. Butler, Raimondo Ascione, Neil V. Marrion, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imaging
W. Stebbeds, Kavita Raniga, David Standing, et al.
Toxicological Sciences (2023) Vol. 195, Iss. 1, pp. 61-70
Open Access | Times Cited: 8
Scaffold-based and scaffold-free cardiac constructs for drug testing
Ken‐ichi Arai, Takahiro Kitsuka, Koichi Nakayama
Biofabrication (2021) Vol. 13, Iss. 4, pp. 042001-042001
Closed Access | Times Cited: 19
Modulating cardiac physiology in engineered heart tissue with the bidirectional optogenetic tool BiPOLES
Barbora Schwarzová, Tim Stüdemann, Muhammed Sönmez, et al.
Pflügers Archiv - European Journal of Physiology (2023) Vol. 475, Iss. 12, pp. 1463-1477
Open Access | Times Cited: 7
Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment
Junjun Li, Ying Hua, Yuting Liu, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108992-108992
Open Access | Times Cited: 2
A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes
Magali Seguret, Patricia M. Davidson, Stijn Robben, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 2
Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
Tromondae K. Feaster, Nicole Feric, Isabella Pallotta, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 11
Cardiotoxicity drug screening based on whole-panel intracellular recording
Yang Yang, Aofei Liu, Ching-Ting Tsai, et al.
Biosensors and Bioelectronics (2022) Vol. 216, pp. 114617-114617
Open Access | Times Cited: 10
Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
Alessandra Maria Lodrini, Lucio Barile, Marcella Rocchetti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 507-507
Open Access | Times Cited: 15
Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers
Wei Feng, Marc Pourrier, David G. Strauss, et al.
Toxicological Sciences (2020) Vol. 174, Iss. 2, pp. 254-265
Closed Access | Times Cited: 15
hiPSC-CM Electrophysiology: Impact of Temporal Changes and Study Parameters on Experimental Reproducibility
Devon Guerrelli, Jenna Pressman, Shatha Salameh, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 327, Iss. 1, pp. H12-H27
Open Access | Times Cited: 1
Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
Philipp Kügler
Jahresbericht der Deutschen Mathematiker-Vereinigung (2020) Vol. 122, Iss. 4, pp. 209-257
Open Access | Times Cited: 10
Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration
Yike Huang, Ting Wang, María Elizabeth Urbina López, et al.
Microphysiological Systems (2020) Vol. 4, pp. 2-2
Open Access | Times Cited: 10
A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes
Magali Seguret, Patricia M. Davidson, Stijn Robben, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 3
Aging Model for Analyzing Drug-Induced Proarrhythmia Risks Using Cardiomyocytes Differentiated from Progeria-Patient-Derived Induced Pluripotent Stem Cells
Neil Daily, Julian Elson, Tetsuro Wakatsuki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11959-11959
Open Access | Times Cited: 3
Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell–Derived Ventricular Cardiomyocytes Using Multielectrode Array
Shuyun Bai, Junjie Pei, Kan Chen, et al.
SLAS DISCOVERY (2020) Vol. 26, Iss. 3, pp. 364-372
Open Access | Times Cited: 6
Assay for evaluation of proarrhythmic effects of herbal products: Case study with 12 Evodia preparations
Bozhidar Baltov, Stanislav Beyl, Igor Baburin, et al.
Toxicology Reports (2023) Vol. 10, pp. 589-599
Open Access | Times Cited: 2
A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell derived cardiomyocytes
Magali Seguret, Patricia M. Davidson, Stijn Robben, et al.
(2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top